Resmed (RMD) Shares Outstanding (Diluted Average) (2009 - 2026)

Resmed (RMD) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $145.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 1.02% year-over-year to $145.7 million; the trailing twelve-month figure through Mar 2026 stood at $145.7 million (down 1.02% YoY), and the FY2025 full-year result was $147.3 million, changed 0.14% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $145.7 million, roughly flat from $146.4 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $147.6 million in Q3 2024 and bottomed at $145.7 million in Q1 2026.
• The 5-year median for Shares Outstanding (Diluted Average) is $147.4 million (2022), against an average of $147.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) increased 0.4%; it then decreased 1.02% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $147.4 million in 2022, then increased by 0.12% to $147.5 million in 2023, then declined by 0.02% to $147.5 million in 2024, then dropped by 0.78% to $146.4 million in 2025, then declined by 0.44% to $145.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $145.7 million (Q1 2026), $146.4 million (Q4 2025), and $146.9 million (Q3 2025), per Business Quant data.

Peer Comparison